Amarin Corp Plc (AMRN)

[exwannabe]

No, there is no "same concern" in the EU as the Anchor patent has held and that is the only one that matters for the EU.

The issue in the US is that generics have been approved for the Marine indication as that patent has failed. That would be a minor issue if not for the fact that they are selling into the Anchor market. That still has a valid patent, but has been almost impossible to effectively enforce.

In the EU there is no Marine indication approved. Thus there are no Marine generics.

In theory somebody could run trials in the Marine indication in the EU and garner an approval for that. In reality that will never happen for economic reasons.